A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
L01 ANTINEOPLASTIC AGENTS
|
L01A ALKYLATING AGENTS
|
L01B ANTIMETABOLITES
|
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
|
L01E PROTEIN KINASE INHIBITORS
|
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
|
L01X OTHER ANTINEOPLASTIC AGENTS
|
L01XA Platinum compounds [DG:DG01679]
|
L01XB Methylhydrazines
|
L01XD Sensitizers used in photodynamic/radiation therapy
|
L01XF Retinoids for cancer treatment
|
L01XG Proteasome inhibitors [DG:DG03134]
|
L01XG01 Bortezomib [DG:DG03219]
|
L01XG02 Carfilzomib
|
D08880 Carfilzomib (JAN/USAN/INN) <JP/US>
|
L01XG03 Ixazomib [DG:DG01269]
|
L01XH Histone deacetylase (HDAC) inhibitors [DG:DG03133]
|
L01XJ Hedgehog pathway inhibitors [DG:DG01566]
|
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors [DG:DG02942]
|
L01XL Antineoplastic cell and gene therapy
|
L01XX Other antineoplastic agents
|
L01XY Combinations of antineoplastic agents
|
L02 ENDOCRINE THERAPY
|
L03 IMMUNOSTIMULANTS
|
L04 IMMUNOSUPPRESSANTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|